novo nordisk patent semaglutide is dismissing its infringement lawsuit against telehealth company Hims & Hers, as the two companies have reached an agreement that will see Novo Nordisk's branded weight loss medicines sold India Obesity Crisis: The Expiry

About half of Americans approve of using weight-loss drugs to treat obesity, AP-NORC poll finds. AP News

Results: Among the 15,411 obtained potential studies, 13 pair-wise trials and 48 monotherapy studies were included in the meta-analysis and NMA, respectively

Buyer Takeaway: Neither choice is automatically "better." It's a cost-versus-regulatory-status trade-off, and it belongs in your provider conversation - not in a box you click past

The temporary discomfort of nausea is often outweighed by the significant health benefits these medications can providebut you dont have to suffer through it alone

Madariaga H, Lee PC, Heitlinger LA, Lebenthal E